If specific subsets of BRCA1mut/+ HMECs normally advance beyond the manifestation of an SFR defect to develop additional BRCA1 functional deficiencies accompanied by a much higher risk of tumorigenicity, their selective elimination might suppress subsequent BRCA1 breast cancer development. The gene discussed is BRCA1; the disease is breast cancer.